Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients

Journal of Human Hypertension volume 30, pages 414–417 (2016)Cite this article

Subjects

Abstract

Associations between high serum uric acid (SUA) levels and high blood pressure (BP), as well as between SUA levels and metabolic syndrome (MetS) have already been reported. The aim of the study was to investigate the relationship between the components of MetS with the SUA levels as also between SUA and apolipoproteins A1 and B (apoA1 and apoB) ratio in hypertensive patients. A total of 2577 consecutive hypertensive patients (1193 male and 1384 female) aged 57.5±13.3 years, were enrolled in our research. Samples were taken to measure SUA, glucose, triglycerides, high density lipoprotein (HDL-C), components of the MetS and apoA1 and apoB. The study population was divided into two groups: group A: SUA levels above normal range (men ⩾7 mg dl−1, women ⩾6 mg dl−1) and group B: SUA levels within normal range. In the overall study population, SUA levels showed a statistically significant correlation with waist circumference (WC; r=0.293, P<0.000), triglycerides (r=0.197, P<0.000), glucose (r=0.085, P<0.000), apoB/apoA1 (r=0.136, P<0.000) and HDL-C (r=−0.235, P<0,001). In newly diagnosed untreated hypertensive patients there was also a statistically significant correlation of SUA levels with WC (r=0.331, P<0.001), triglycerides (r=0.228, P<0.001) apoB/apoA1 ratio (r=0.202, P<0.001) and HDL-C (r=−0.278, P<0.001). In hyperurecemic hypertensives there was a statistically significant correlation between SUA levels with WC (r=0.168, P=0.007), apoB/apoA1 ratio (r=0.256, P=0.003) and HDL-C (r=−0.202, P<0.001). SUA levels correlate significantly with all the components of MetS, as well as with the risk factor apoB/apoA1 ratio, in hypertensive patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R et al. Is it time to revise the normal range of serum uric acid levels? Eur Rev Md Pharmacol Sci 2014; 18 (9): 1295–1306.

    CAS  Google Scholar 

  2. Fang J, Alderman MH . Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283 (18): 2404–2410.

    Article  CAS  PubMed  Google Scholar 

  3. Ofori SN, Odia OJ . Serum uric acid and target organ damage in essential hypertension. Vasc Health Risk Manag 2014; 10: 253–261.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mule G, Riccobene R, Castiglia A, D’Ignoto F, Ajello E, Geraci G et al. Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients. Nutr Metab Cardiovasc Dis 2014; 24 (7): 744–750.

    Article  CAS  PubMed  Google Scholar 

  5. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112 (20): 3066–3072.

    Article  CAS  PubMed  Google Scholar 

  6. Knowles JW, Reaven G . Hyperuricemia: the unintended consequence of insulin resistance/compensatory hyperinsulinemia. J Intern Med 2014; 276 (2): 196–198.

    Article  CAS  PubMed  Google Scholar 

  7. Ciarla S, Struglia M, Giorgini P, Striuli R, Necozione S, Properzi G et al. Serum uric acid levels and metabolic syndrome. Arch Physiol Biochem 2014; 120 (3): 119–122.

    Article  CAS  PubMed  Google Scholar 

  8. Billiet L, Doaty S, Katz JD, Velasquez MT . Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014; 2014: 852954.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S . Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 2014; 63 (3): 976–981.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lu M, Lu Q, Zhang Y, Tian G . ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity. J Biomed Res 2011; 25 (4): 266–273.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Panayiotou A, Griffin M, Georgiou N, Bond D, Tyllis T, Tziakouri-Shiakalli C et al. ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol 2008; 27 (1): 74–80.

    CAS  PubMed  Google Scholar 

  12. Morrison JA, Glueck CJ, Daniels SR, Horn PS, Wang P . Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study. Metabolism 2012; 61 (10): 1377–1387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kostapanos MS, Christogiannis LG, Bika E, Bairaktari ET, Goudevenos JA, Elisaf MS et al. Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects. J Stroke Cerebrovasc Dis 2010; 19 (6): 497–502.

    Article  PubMed  Google Scholar 

  14. Wang SH, Sun ZL, Ruan XZ, Guo YJ, Wang Y, Jin H et al. Dyslipidaemia among diabetic patients with ischemic stroke in a Chinese hospital. Chin Med J 2009; 122 (21): 2567–2572.

    CAS  PubMed  Google Scholar 

  15. Peristein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M et al. Uric acid and the development of hypertension. Hypertension American Heart association 2006; 48: 1031.

    Google Scholar 

  16. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R et al. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994; 8 (9): 677–681.

    CAS  PubMed  Google Scholar 

  17. Dawson J, Jeemon P, Hetherington L, Judd C, Hastie C, Schulz C et al. Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension 2013; 62: 105–111.

    Article  CAS  PubMed  Google Scholar 

  18. Forman JP, Choi H, Curhan GC . Plasma uricacid level and risk for incident hypertension among men. J Am Soc Nephrol 2007; 18 (1): 287–292.

    Article  CAS  PubMed  Google Scholar 

  19. Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A et al. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J 2007; 28 (21): 2637–2643.

    Article  CAS  PubMed  Google Scholar 

  20. Lind L, Vessby B, Sundström J . The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men. Arterioscler Thromb Vasc Biol 2006; 26 (2): 406–410.

    Article  CAS  PubMed  Google Scholar 

  21. Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J et al. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J 2009; 30 (6): 710–717.

    Article  CAS  PubMed  Google Scholar 

  22. Savas Erdeve S, Simsek E, Dallar Y, Biyikli Z . Utility of ApoB/ApoA1 ratio for the prediction of cardiovascular risk in children with metabolic syndrome. Indian J Pediatr 2010; 77 (11): 1261–1265.

    Article  CAS  PubMed  Google Scholar 

  23. Smith J, Al-Amri M, Sniderman A, Cianflone K . Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Nutr Metab 2006; 3: 18.

    Article  Google Scholar 

  24. Sabino AP, De Oliveira Sousa M, Moreira Lima L, Dias Ribeiro D, Sant’Ana Dusse LM, Das Graças Carvalho M et al. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease. Transl Res 2008; 152 (3): 113–118.

    Article  CAS  PubMed  Google Scholar 

  25. Galvan AQ, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268: E1–E5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Sismanoglio General Hospital, Athens, Greece

    M V Papavasileiou, A G Karamanou, G Moustakas & S Patsianis

  2. Department of Cardiology, Agioi Anargyroi General Hospital, Athens, Greece

    P Kalogeropoulos

  3. Department of Cardiology, Mediton Cardiology Center, Athens, Greece

    A Pittaras

Authors
  1. M V Papavasileiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A G Karamanou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Kalogeropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Moustakas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Patsianis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Pittaras
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A G Karamanou.

Ethics declarations

Competing interests

The authors declare no conflict of interest

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papavasileiou, M., Karamanou, A., Kalogeropoulos, P. et al. Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients. J Hum Hypertens 30, 414–417 (2016). https://doi.org/10.1038/jhh.2015.53

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2015.53

This article is cited by

Search

Advanced search

Quick links